1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Early Stage HER2-Positive Breast Carcinoma: new trials by email Literature Review of Early Stage HER2-Positive Breast Carcinoma trials Research Report on Early Stage HER2-Positive Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial Biospecimen Collection, Hormone Therapy, Pembrolizumab - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 120 | 2025-10-09 | 2026-09-24 |
2C4 antibody (1) · CT-P6 (1) · Hormones (1) · Ogivri (1) · Ontruzant (1) · PF-05280014 (1) · Specimen Handling (1) · Steroids (1) · Trastuzumab (1) · pembrolizumab (1) · pertuzumab (1) · trastuzumab biosimilar HLX02 (1)
M.D. Anderson Cancer Center (1)
United States (1)
P30CA016672 (1)